Risk factors for systemic emboli in infective endocarditis

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Herpes zoster in non-hospitalized children

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Migrant health—a cause for concern?

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Escherichia coli native valve endocarditis

Vector control: a cornerstone in the malaria elimination campaign

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Training for the infectious diseases speciality in Norway

An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus P.O. Verhoeven, F. Grattard,

Community-acquired pneumonia: the evolving challenge

Retrospective study of CMV retinitis in patients with AIDS

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards P. Berthelot,

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

M. Daudin, P. Tattevin, B. Lelong, E. Flecher, S. Lavoué, C. Piau, A

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona S. Borrell, G. Tudó, E. Rey, J. González-Martín

Current experience in treating invasive zygomycosis with posaconazole

Antimicrobial drug development – the past, the present, and the future

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Community-acquired acute bacterial meningitis in the elderly in Turkey

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Risk factors for systemic emboli in infective endocarditis C. Deprèle, Ph. Berthelot, F. Lemetayer, C. Comtet, A. Fresard, C. Cazorla, P. Fascia, P. Cathébras, G. Chaumentin, G. Convert, K. Isaaz, X. Barrai, F. Lucht Clinical Microbiology and Infection Volume 10, Issue 1, Pages 46-53 (January 2004) DOI: 10.1111/j.1469-0691.2004.00735.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Time elapsed before occurrence of emboli. Clinical Microbiology and Infection 2004 10, 46-53DOI: (10.1111/j.1469-0691.2004.00735.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Cumulative probability of embolic episodes in the studied population (including the 17 patients who had emboli before the first TEE). Clinical Microbiology and Infection 2004 10, 46-53DOI: (10.1111/j.1469-0691.2004.00735.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Actuarial survival: embolic risk according to the size of the vegetation. Clinical Microbiology and Infection 2004 10, 46-53DOI: (10.1111/j.1469-0691.2004.00735.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions